Latest filing published 05 May 2025 for Sutro Biopharma, INC..
Insider track record
Anne Elizabeth Borgman: trading record in brief
Anne Elizabeth Borgman is a declared insider of Sutro Biopharma, Inc., with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 29 February 2024 to 1 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 5 May 2025: an option exercise, in Sutro Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anne Elizabeth Borgman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,938 shares0Common StockSEC:0001415889-25-011996:1
- 24,709 shares@ US$1.0720.6% of flowCommon StockSEC:0001415889-25-011996:2
- 53,125 shares0Common StockSEC:0001415889-25-011996:0
- 11,250 shares0Common StockSEC:0001415889-25-006655:2
- 15,405 shares@ US$1.5920.8% of flowCommon StockSEC:0001415889-25-006655:1
- 4,621 shares@ US$1.596.2% of flowCommon StockSEC:0001415889-25-006655:3
- 37,500 shares0Common StockSEC:0001415889-25-006655:0
- 13,126 shares@ US$4.9152.4% of flowCommon StockSEC:0001415889-24-006267:1
- 37,500 shares0Common StockSEC:0001415889-24-006267:0
9 of 9 declarations